Lonza Expands Pearland Pharmaceutical Manufacturing Facility

Global pharmaceutical manufacturer Lonza is expanding its production facilities in Pearland, Texas. Work began in March of 2016 on a 100,000-sf clinical manufacturing center, which will begin operations in late 2017. A second phase of construction will begin in fall of 2016 at the site, providing an additional 150,000 sf of office, laboratory, and manufacturing space. The completed 250,000-sf campus will support commercial production of viral gene and cell therapies and will feature eight independent cGMP modular cleanrooms with single-use bioreactors and a fully segregated fill/finish suite. Lonza is based in Basel, Switzerland.